Buspirone Counteracts MK-801-Induced Schizophrenia-Like Phenotypes through Dopamine D3 Receptor Blockade

Safety and tolerability of cariprazine in patients with acute exacerbation of schizophrenia

(2017) Willie Earley et al.   INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY

D3 Receptors Regulate Excitability in a Unique Class of Prefrontal Pyramidal Cells

(2017) Rebecca L. Clarkson et al.   JOURNAL OF NEUROSCIENCE

Separate elements of episodic memory subserved by distinct hippocampal–prefrontal connections

(2017) Gareth R I Barker et al.   NATURE NEUROSCIENCE

5-HT2C Agonists Modulate Schizophrenia-Like Behaviors in Mice

(2017) Vladimir M Pogorelov et al.   NEUROPSYCHOPHARMACOLOGY

The effects of buspirone on occupancy of dopamine receptors and the rat gambling task

(2017) Patricia Di Ciano et al.   PSYCHOPHARMACOLOGY

Y-QA31, a novel dopamine D3 receptor antagonist, exhibits antipsychotic-like properties in preclinical animal models of schizophrenia

(2016) Xue Sun et al.   ACTA PHARMACOLOGICA SINICA

The dopamine D3 receptor, a quarter century later

(2016) Pierre Sokoloff et al.   EUROPEAN JOURNAL OF NEUROSCIENCE

Schizophrenia

(2016) Michael J Owen et al.   LANCET

Current drug treatments targeting dopamine D3 receptor

(2016) Gian Marco Leggio et al.   PHARMACOLOGY & THERAPEUTICS

Genetic Disruption of Arc/Arg3.1 in Mice Causes Alterations in Dopamine and Neurobehavioral Phenotypes Related to Schizophrenia

(2016) Francesca Managò et al.   Cell Reports

Dopamine D3 Receptor Antagonists as Potential Therapeutics for the Treatment of Neurological Diseases

(2016) Samuele Maramai et al.   Frontiers in Neuroscience

Neural circuitry for rat recognition memory

(2015) E.C. Warburton et al.   BEHAVIOURAL BRAIN RESEARCH

Dopamine D3 receptor-dependent changes in alpha6 GABAA subunit expression in striatum modulate anxiety-like behaviour: Responsiveness and tolerance to diazepam

(2015) Gian Marco Leggio et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

The mRNA Expression Status of Dopamine Receptor D2, Dopamine Receptor D3 and DARPP-32 in T Lymphocytes of Patients with Early Psychosis

(2015) Yin Cui et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Molecular substrates of schizophrenia: homeostatic signaling to connectivity

(2015) M A Landek-Salgado et al.   MOLECULAR PSYCHIATRY

Targeting Dopamine D3 and Serotonin 5-HT1A and 5-HT2A Receptors for Developing Effective Antipsychotics: Synthesis, Biological Characterization, and Behavioral Studies

(2014) Margherita Brindisi et al.   JOURNAL OF MEDICINAL CHEMISTRY

Oleanolic acid attenuates MK-801-induced schizophrenia-like behaviors in mice

(2014) Se Jin Park et al.   NEUROPHARMACOLOGY

Dopamine D3 Receptor Is Necessary for Ethanol Consumption: An Approach with Buspirone

(2014) Gian Marco Leggio et al.   NEUROPSYCHOPHARMACOLOGY

Neurocognition in schizophrenia: From prodrome to multi-episode illness

(2014) Valentina Corigliano et al.   PSYCHIATRY RESEARCH

Effect of blonanserin on cognitive and social function in acute phase Japanese schizophrenia compared with risperidone

(2014) Hikaru Hori et al.   Neuropsychiatric Disease and Treatment

Modulation of Hippocampus-Prefrontal Cortex Synaptic Transmission and Disruption of Executive Cognitive Functions by MK-801

(2013) K. Blot et al.   CEREBRAL CORTEX

The potential role of dopamine D3 receptor neurotransmission in cognition

(2013) Shinichiro Nakajima et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

Dopamine D3 receptor antagonism—still a therapeutic option for the treatment of schizophrenia

(2013) Gerhard Gross et al.   NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY

Investigations into the involvement of NMDA mechanisms in recognition memory

(2013) E. Clea Warburton et al.   NEUROPHARMACOLOGY

NMDA hypofunction as a convergence point for progression and symptoms of schizophrenia

(2013) Melissa A. Snyder et al.   Frontiers in Cellular Neuroscience

Modification of cocaine self-administration by buspirone (buspar®): potential involvement of D3 and D4 dopamine receptors

(2012) Jack Bergman et al.   INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY

Pharmacological treatment of schizophrenia: a critical review of the pharmacology and clinical effects of current and future therapeutic agents

(2012) S Miyamoto et al.   MOLECULAR PSYCHIATRY

Cariprazine, a dopamine D3-receptor-preferring partial agonist, blocks phencyclidine-induced impairments of working memory, attention set-shifting, and recognition memory in the mouse

(2012) Ross Zimnisky et al.   PSYCHOPHARMACOLOGY

The role of 5-HT1A receptors in phencyclidine (PCP)-induced novel object recognition (NOR) deficit in rats

(2012) M. Horiguchi et al.   PSYCHOPHARMACOLOGY

Animal models of schizophrenia

(2011) CA Jones et al.   BRITISH JOURNAL OF PHARMACOLOGY

Antipsychotic-induced catalepsy is attenuated in mice lacking the M4 muscarinic acetylcholine receptor

(2011) Anders Fink-Jensen et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

When Is the Hippocampus Involved in Recognition Memory?

(2011) G. R. I. Barker et al.   JOURNAL OF NEUROSCIENCE

Selective Blockade of Dopamine D3 Receptors Enhances while D2 Receptor Antagonism Impairs Social Novelty Discrimination and Novel Object Recognition in Rats: A Key Role for the Prefrontal Cortex

(2011) David JG Watson et al.   NEUROPSYCHOPHARMACOLOGY

Effects of olanzapine, sertindole and clozapine on MK-801 induced visual memory deficits in mice

(2011) Oguz Mutlu et al.   PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR

Is the Acute NMDA Receptor Hypofunction a Valid Model of Schizophrenia?

(2011) A. Adell et al.   SCHIZOPHRENIA BULLETIN

N-methyl-d-aspartate (NMDA) receptor dysfunction or dysregulation: The final common pathway on the road to schizophrenia?

(2010) Joshua T. Kantrowitz et al.   BRAIN RESEARCH BULLETIN

Dopamine D3 receptor knock-out mice exhibit increased behavioral sensitivity to the anxiolytic drug diazepam

(2010) Gian Marco Leggio et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

A Double-Blind, Randomized, and Placebo-Controlled Trial of Buspirone Added to Risperidone in Patients With Chronic Schizophrenia

(2010) Ali Ghaleiha et al.   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY

Dysbindin-1 modulates prefrontal cortical activity and schizophrenia-like behaviors via dopamine/D2 pathways

(2010) F Papaleo et al.   MOLECULAR PSYCHIATRY

The Antipsychotics Olanzapine, Risperidone, Clozapine and Haloperidol Are D2-Selective Ex Vivo but Not In Vitro

(2010) Patrick N McCormick et al.   NEUROPSYCHOPHARMACOLOGY

Effect of tandospirone, a serotonin-1A receptor partial agonist, on information processing and locomotion in dizocilpine-treated rats

(2010) Vera Bubenikova-Valesova et al.   PSYCHOPHARMACOLOGY

Treatment of cognitive dysfunction in chronic schizophrenia by augmentation of atypical antipsychotics with buspirone, a partial 5-HT1Areceptor agonist

(2009) Danijela Piškulić et al.   HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL

The dopamine D3 receptor (DRD3) gene and risk of schizophrenia: Case–control studies and an updated meta-analysis

(2009) Ayako Nunokawa et al.   SCHIZOPHRENIA RESEARCH

Impairment of Working Memory Maintenance and Response in Schizophrenia: Functional Magnetic Resonance Imaging Evidence

(2008) Naomi R. Driesen et al.   BIOLOGICAL PSYCHIATRY

Models of schizophrenia in humans and animals based on inhibition of NMDA receptors

(2008) Věra Bubeníková-Valešová et al.   NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS